rs1415701
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_032438.4(L3MBTL3):c.-16+2385G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 151,980 control chromosomes in the GnomAD database, including 7,476 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.31 ( 7476 hom., cov: 32)
Consequence
L3MBTL3
NM_032438.4 intron
NM_032438.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0120
Publications
42 publications found
Genes affected
L3MBTL3 (HGNC:23035): (L3MBTL histone methyl-lysine binding protein 3) This gene encodes a member of the malignant brain tumor (MBT) family of chromatin interacting transcriptional repressors. Members of this family function as methyl-lysine readers, which recognize methylated lysine residues on histone protein tails, and are associated with the repression of gene expression. The encoded protein may regulate hematopoiesis. Homozygous deletion of this gene has been observed in human patients with medulloblastoma. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.385 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| L3MBTL3 | NM_032438.4 | c.-16+2385G>A | intron_variant | Intron 2 of 22 | ENST00000361794.7 | NP_115814.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| L3MBTL3 | ENST00000361794.7 | c.-16+2385G>A | intron_variant | Intron 2 of 22 | 5 | NM_032438.4 | ENSP00000354526.2 |
Frequencies
GnomAD3 genomes AF: 0.306 AC: 46492AN: 151862Hom.: 7472 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
46492
AN:
151862
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.306 AC: 46529AN: 151980Hom.: 7476 Cov.: 32 AF XY: 0.306 AC XY: 22712AN XY: 74290 show subpopulations
GnomAD4 genome
AF:
AC:
46529
AN:
151980
Hom.:
Cov.:
32
AF XY:
AC XY:
22712
AN XY:
74290
show subpopulations
African (AFR)
AF:
AC:
15987
AN:
41466
American (AMR)
AF:
AC:
5111
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
655
AN:
3466
East Asian (EAS)
AF:
AC:
2059
AN:
5150
South Asian (SAS)
AF:
AC:
1355
AN:
4826
European-Finnish (FIN)
AF:
AC:
2495
AN:
10570
Middle Eastern (MID)
AF:
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17911
AN:
67916
Other (OTH)
AF:
AC:
673
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1640
3280
4920
6560
8200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1151
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.